Drug Profile
ONO 6818
Latest Information Update: 03 Dec 2002
Price :
$50
*
At a glance
- Originator Cortech; Ono Pharmaceutical
- Class Oxadiazoles; Pyrimidinones
- Mechanism of Action Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 03 Dec 2002 Discontinued - Phase-I for Chronic obstructive pulmonary disease in Japan (PO)
- 03 Dec 2002 Discontinued - Phase-I for Chronic obstructive pulmonary disease in USA (PO)
- 27 Sep 2002 Suspended - Phase-I for Chronic obstructive pulmonary disease in USA (PO)